Document Detail

The angiotensin converting enzyme insertion/deletion polymorphism alters the response of muscle energy supply lines to exercise.
Jump to Full Text
MedLine Citation:
PMID:  23397151     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
The presence of a silencing sequence (the I-allele) in the gene for the upstream regulator of blood flow, angiotensin I-converting enzyme (ACE), is associated with superior endurance performance and its trainability. We tested in a retrospective study with 36 Caucasian men of Swiss descent whether carriers of the ACE I-allele demonstrate a modified adaptive response of energy supply lines in knee extensor muscle, and aerobic fitness, to endurance training based on 6 weeks of supervised bicycle exercise or 6 months of self-regulated running (p value <Bonferroni-corrected 5 %). Body weight related maximal oxygen uptake and capillary density in vastus lateralis muscle before training were 20 and 23 % lower, respectively, in carriers of the I-allele. Bicycle (n = 16) but not running type endurance training (n = 19) increased the volume content of subsarcolemmal mitochondria (2.5-fold) and intramyocellular lipid (2.1-fold). This was specifically amplified in I-allele carriers after 6 weeks of bicycle exercise. The enhanced adjustment in myocellular organelles of aerobic metabolism with bicycle training corresponded to ACE I-allele dependent upregulation of 23 muscle transcripts during recovery from the bicycle stimulus and with training. The majority of affected transcripts were associated with glucose (i.e. ALDOC, Glut2, LDHC) and lipid metabolism (i.e. ACADL, CPTI, CPTII, LIPE, LPL, FATP, CD36/FAT); all demonstrating an enhanced magnitude of change in carriers of the ACE I-allele. Our observations suggest that local improvements in mitochondrial metabolism, through a novel expression pathway, contribute to the varying trainability in endurance performance between subjects with genetically modified expression of the regulator of vascular tone, ACE.
Authors:
David Vaughan; Felicitas A Huber-Abel; Franziska Graber; Hans Hoppeler; Martin Flück
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2013-2-9
Journal Detail:
Title:  European journal of applied physiology     Volume:  -     ISSN:  1439-6327     ISO Abbreviation:  Eur. J. Appl. Physiol.     Publication Date:  2013 Feb 
Date Detail:
Created Date:  2013-2-11     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100954790     Medline TA:  Eur J Appl Physiol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
Institute for Biomedical Research into Human Movement and Health, School of HealthCare Science, Manchester Metropolitan University, Chester Street, Manchester, M1 5GD, UK.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Full Text
Journal Information
Journal ID (nlm-ta): Eur J Appl Physiol
Journal ID (iso-abbrev): Eur. J. Appl. Physiol
ISSN: 1439-6319
ISSN: 1439-6327
Publisher: Springer-Verlag, Berlin/Heidelberg
Article Information
Download PDF
© The Author(s) 2013
OpenAccess:
Received Day: 10 Month: 2 Year: 2012
Accepted Day: 28 Month: 12 Year: 2012
Electronic publication date: Day: 9 Month: 2 Year: 2013
pmc-release publication date: Day: 9 Month: 2 Year: 2013
Print publication date: Month: 7 Year: 2013
Volume: 113 Issue: 7
First Page: 1719 Last Page: 1729
PubMed Id: 23397151
ID: 3677975
Publisher Id: 2583
DOI: 10.1007/s00421-012-2583-6

The angiotensin converting enzyme insertion/deletion polymorphism alters the response of muscle energy supply lines to exercise
David VaughanAff1
Felicitas A. Huber-AbelAff2
Franziska GraberAff2
Hans HoppelerAff2
Martin FlückAff1Aff3 Address: +44-161-2475417 +44-161-2476375 m.flueck@mmu.ac.uk mflueck@research.balgrist.ch
Institute for Biomedical Research into Human Movement and Health, School of HealthCare Science, Manchester Metropolitan University, Chester Street, Manchester, M1 5GD UK
Department of Orthopaedics, University of Zürich, Balgrist University Hospital, Zurich, Switzerland
Department of Anatomy, University of Berne, Berne, Switzerland
Communicated by footnote: Communicated by Klaas R Westerterp.

Introduction

Variability in the response of aerobic capacity (VO2max) to endurance training is a common observation in human experimentation (Bouchard and Rankinen 2001; Timmons 2011). Pre-training status and familial factors such as shared environment and genetics have been proposed to explain inter-subject differences in the response to regular physical activity (Bouchard and Rankinen 2001). A volumetric increase in cellular constituents of energy supply (i.e. capillarity, mitochondria and intramyocellular lipid) in vastus lateralis muscle makes an important local contribution to the increase in VO2max with endurance training (Hoppeler et al. 1985; Hoppeler and Weibel 1998). Plasticity of energy supply lines in muscles being recruited during leg exercise (Krustrup et al. 2004) likely contributes to inter-individual differences in the response of aerobic metabolism to training.

A number of gene polymorphisms have been identified, which relate to differences in the exercise phenotype and their trainability (Bray et al. 2009). A commonly studied candidate for genetically determined physical performance is the presence of an insertion DNA sequence comprising a silencer region within intron 16 of the ACE gene (the I-allele; Myerson et al. 1999), which occurs frequently in Caucasian populations (Lester et al. 1999). The presence of the ACE I-allele in ACE-II and ACE-ID genotypes (i.e. I-allele carriers) is associated with elevated endurance performance and its trainability compared to homozygotes of the D-allele (i.e. ACE-DD genotypes) that do not carry the ACE I-allele (Jones et al. 2002; Myerson et al. 1999). For instance, Myerson et al. (1999) and Alvarez et al. (2000) report that the frequency of the ACE I-allele is increased in subjects with elite endurance performance. The effect of carrying the I-allele is related to lowered expression and activity of the encoded ACE enzyme (Almeida et al. 2010; Alvarez et al. 2000; Rigat et al. 1990). This enzyme catalyses the proteolytic conversion of angiotensin 1 into the bioactive vasoconstrictory peptide angiotensin 2 (Ang2), (Munzenmaier and Greene 1996), while accelerating degradation of kinins that act as vasodilators (Dietze and Henriksen 2008; Woods et al. 2002).

The mechanism driving the association of endurance performance with the ACE I/D-allele polymorphism with specific emphasis for working muscle is not understood (Baker and Davids 2006). A number of processes downstream of ACE activity have been suggested to contribute to elevated trainability of endurance performance in carriers of the ACE I-allele (Puthucheary et al. 2011). Potentially, this involves Ang2 and kinin modulated glucose and triglyceride supply and metabolism in working muscle (Dietze and Henriksen 2008; Jamerson et al. 1996) or vascular processes associated with contraction-induced inhibition of Ang2 regulated smooth muscle cell contractility that allows recruitment of new capillaries to perfusion (Brothers et al. 2006). In this regard, Ang2-mediated modification of angiogenesis by Ang2-stimulated endothelial cell proliferation (Amaral et al. 2001; Bellamy et al. 2010; Munzenmaier and Greene 1996) is of particular interest. Indeed, exercise-induced capillary growth is related to increased expression of angiogenic gene transcripts in skeletal muscle post exercise (Yan et al. 2011), and a number of genes have been shown recently to lie downstream of Ang2 signalling (Song et al. 2011). There is evidence that genetically modified ACE expression in mice alters muscle capillarity (Zhang et al. 2005) and that the ACE I/D polymorphism affects fibre type distribution (Zhang et al. 2003). A scenario is suggested whereby soluble mediators of ACE action reaching the vascular bed of skeletal muscle upon contraction-induced vasodilatation regulate muscle perfusion and drive capillary growth during recovery from exercise.

We reasoned that the effect of the ACE I/D polymorphism on aerobic fitness has a muscle component related to exercise-induced capillary growth and substrate supply. Specifically, we hypothesised that ACE-DD genotypes compared to carriers of the I-allele (II and ID genotypes) would demonstrate an amplified gene response of angiogenic and metabolic pathways in the knee extensor muscle, vastus lateralis, and corresponding cellular endpoints of energy supply (i.e. capillarity, lipid and mitochondrial content) to single and repeated endurance exercise during training. Differences in the association between endurance phenotypes and the ACE I-allele have been studied in endurance runners and cyclists (Alvarez et al. 2000; Myerson et al. 1999) and have been suggested to be modulated by the type/intensity of endurance training (Cam et al. 2007). We, therefore, tested whether adjustments of energy supply lines in vastus lateralis muscle as a function of the ACE I-allele would differ between bicycle and running type endurance training.


Materials and methods
Experimental design

A retrospective experiment was carried out in two groups of healthy Caucasian men of Swiss descent to characterize skeletal muscle’s response to endurance training in function of the ACE I-allele. Therefore, genotyping for the ACE I/D polymorphism was carried out on samples from vastus lateralis muscle that had been subjected to the analysis of muscle structure and aerobic capacity before and after participants completed two types of endurance training based on (1) bicycle (group one) or (2) running (group two) exercise. Transcript profiling was performed on biopsy samples of vastus lateralis muscle from the bicycle group being collected prior and over a time course over the first 24 h of recovery from the first endurance exercise test on a stationary bicycle. M. vastus lateralis was chosen as the study object due to its important recruitment during the exercise tests on the bicycle and training (Krustrup et al. 2004).

Subjects

The study characterises 36 healthy Caucasian subjects of Swiss descent. This comprised a first group involving 17 not systematically trained men which underwent endurance training on a stationary bicycle as described (Schmutz et al. 2006, 2010). The second group includes 19 men who underwent running type endurance training as reported (Suter et al. 1995). Age, height and body weight were recorded for all subjects. The investigations were conducted with permission of the Ethics Committee of Bern, Switzerland, in compliance with the Helsinki Convention for Research on human participants.

Genotyping

DNA isolation was performed from pooled cryosections of approximately 10 mg tissue of M. vastus lateralis following a commercially available protocol (Qiagen DNeasy Blood and Tissue Handbook, 07/2006, cat. no. 69504). ACE I/D genotyping was carried out with polymerase chain reaction (PCR) as described by Evans et al. (1994) on isolated DNA. The primers corresponded to those established previously for the identification of the ACE I/D polymorphism (for details see Genbank number X62855):

Detection of the 83 bp amplicon specific to the absence of the insertion sequence (i.e. the D-allele) was achieved by a combination of ACE1 (5′-catcctttctcccatttctc-3′) and ACE3 (5′-atttcagagctggaataaaatt-3′) primers. ACE2 (5′-tgggattacaggcgtgatacag-3′) and ACE3 (5′-atttcagagctggaataaaatt-3′) primers were applied to detect the 66 bp amplicon specific for the I-allele in intron 16 of the ACE gene.

PCR reactions were run with a mix of the three primers using Sybr Green master mix (Applied Biosystems) on a Biorad DNA machine controlled by the MJ Opticon Monitor software (Biorad). This involved 45 standard cycles of denaturing at 95 °C for 15 s followed by annealing and extension at 55 °C for 1 min. Amplicon identification followed using a melting curve analysis between a temperature range of 70–80 °C. Identity of the amplified sequence for the ACE-I and ACE-D allele was validated by sequencing of the PCR products with the specific primers (Microsynth, Balgach, Switzerland). Presence of the short amplicon for the I-allele was identified by lower melting temperature (73.5 °C) compared to the longer D-allele (75.5 °C). Samples with poor signal to noise ratio were re-run in separate reactions with the specific primer pair for amplification of either the I-allele or D-allele.

Whole body aerobic capacity

Before and after endurance training, VO2max in [L O2 min-1] was determined with ergospirometry in an incremental endurance test on a stationary bicycle ergometer (Jaeger, Ergoline 800S, Bitz, Germany) as described (Schmutz et al. 2006; Suter et al. 1995). The exercise started with 40 W, the workload being increased by 30 W every 2 min until the subjects could no longer maintain a cadence of more than 60 rpm. Criteria for the achievement of VO2max were a non-linear increase in VO2 and lactate levels >7 mM and a respiratory exchange ratio >1.1. Subsequently, body weight related VO2max (i.e. relative VO2max) was calculated and given in the units [mL O2 min-1, kg-1].

Endurance exercise test

Subjects of group one reported to the laboratory in the morning after an overnight fast. A resting biopsy was collected from vastus lateralis muscle in the rested state. On a separate occasion, 57 ± 4 h later, VO2max was determined. Two weeks later participants reported to the laboratory after an overnight fast. They carried out a bout of two-legged endurance exercise on the Ergoline 800S ergometer consisting of a warm-up of 10 min at 40 % of PPO (peak power output) followed by 30 min of cycling at 65 % PPO. Oxygen consumption was recorded during the exercise. Muscle biopsies were collected 1, 3, 8 and 24 h after exercise from vastus lateralis muscle in alternating order from new incision sites in the left or right leg, frozen in nitrogen-cooled isopentane and stored in liquid nitrogen.

Endurance training

Subjects enrolled in either of two endurance-training programs. Group one entered a supervised bicycle-training program subsequent to the single bout of exercise. This comprised five controlled 30 min exercise sessions per week on a stationary bicycle ergometer (Kettler, Ense-Parsit, Germany) at 65 % PPO for a total of 6 weeks. Each training session was monitored based on heart rate measures with a chest belt (Accurex Plus, Polar Electro Finland, Kempele, Finland) and adjusted to maintain a constant individual training intensity at approximately 90 % of maximal heart rate. In addition, training workload was followed by Borg’s Perceived Exertion and Pain Scale and weekly measures of lactate during exercise (finger tip, Yellow Springs Lactate Analyzer 23L). At the end of the training period after 3 days of rest, a post training biopsy was collected from vastus lateralis muscle. Whole body aerobic capacity was re-assessed 3 days later. One subject dropped out due to an unrelated accident.

Subjects from group two had their whole body aerobic capacity determined 3 weeks before entering a 6-month endurance exercise training program composed of home-based running of attempted 4 × 30 min per week for 6 months at an intensity corresponding to 75 % VO2max as described (Suter et al. 1995). Participants were instructed to keep a training diary, containing the heart rate, time and distance covered during each training session. They had to control their heart rate during exercise and recovery with a portable heart rate monitor (Polar Edge, Polar Electro, Kempele, Finland). Subjects were instructed to maintain the heart rate during the running exercise to a value corresponding to 75 % VO2max as determined in the lab-based test. Only subjects meeting the criteria of an average training duration of 60 min per week were included in this analysis. The average training activity over the 6 months training period was 105 min and 18.8 km per week. After endurance training, whole body aerobic capacity was reassessed. Biopsies were collected pre and post endurance training with Bergstroem needles, frozen in nitrogen-cooled isopentane and stored in liquid nitrogen until further analysis was performed.

Muscle structure

Quantitative alterations in muscle ultrastructure were evaluated with established morphometric technique from glutaraldehyde-fixed muscle biopsies (Schmutz et al. 2006). In brief, this comprised the assessment of volume densities of myofibrils, total mitochondria, subsarcolemmal mitochondria, intramyocellular lipids, residual organelles and capillaries. In addition, mean muscle fibre cross sectional area (CSA), capillary-to-fibre ratio and slow fibre type content were estimated (Suter et al. 1995).

Transcript profiling

Level alterations of 231 gene transcripts were assessed in total RNA from a subset of bicycle-trained subjects prior to and during recovery from bicycle exercise in the untrained state and after bicycle training with validated low-density Atlas® cDNA arrays (BD Biosciences, Allschwil, Switzerland; (Schmutz et al. 2006). The genes included on the array platform covered major gene ontologies (GO) underlying muscle energy and protein metabolism, fibre structure, cell regulation and angiogenesis (GPL 1935, Gene Omnibus: http://www.ncbi.nlm.nih.gov/geo). The selected time points (i.e. 1, 8 and 24 h) were chosen in reference to the peak response of transcript expression in untrained subjects (Schmutz et al. 2006). Microarray data series were deposited under accession codes GSE 13623 and GSE 2479, respectively, at Gene Omnibus.

Statistical analysis

Data were organised in MS-Excel and exported into Statistica 9 (Statsoft) for statistical testing. Physiological and structural variables were assessed with a Student’s t test. A one-factorial ANOVA was carried out to assess the effect of carrying the ‘ACE I-allele’ (i.e. combined ACE-II and ACE-ID genotypes vs. the ACE-DD genotype) for the measured parameters (ultrastructural variables, relative and absolute VO2max, PPO). The interaction effect of the co-variable of ‘body weight’ and the ‘ACE I-allele’ on relative and absolute VO2max was assessed with a general (non)linear model. A repeated ANOVA was used to compare ‘post versus pre’ effects of exercise or training and its interaction with the ‘ACE I-allele’. For the latter test, the data were normalized to the mean value for the respective genotype prior to training. The calculated p values (α = 0.05 except stated otherwise) of the post hoc tests were adjusted for the error of testing multiple, independent hypotheses (m) by applying a Bonferroni correction (i.e. setting the new p value to α/m). Effects were called significant at the Bonferroni-corrected p-value when p < α/m.

The evaluation of the gene expression data was as follows: Microarray data were background corrected as described (Schmutz et al. 2010). Subsequently, background-corrected signals were related to the total count of transcript signal per array to reveal normalized values. Significant adjustments in muscle transcript expression following a single bout of endurance exercise and training between carriers and non-carriers of the ACE I-allele were evaluated from normalized values using a Significance Analysis of Microarrays test (SAM) running as an applet in Microsoft Excel software (Tusher et al. 2001). Default settings for two-class, paired data with post hoc t tests were used during the calculation. A q value being adjusted for the number of assessed gene transcripts (i.e. 5 %/231) was deemed appropriate to identify differently expressed gene transcripts.

Visualization of fold differences in transcript expression was achieved through treatment of the data with Cluster and Treeview software (http://rana.lbl.gov/EisenSoftware.htm). Postscript files were imported into CorelDraw X3 (Corel Corp.) and assembled in Powerpoint (MS-Office for Windows XP, Kildare, Ireland). Genmaps were constructed using Genmapp (www.genmapp.org).


Results
Differences in aerobic capacity between carriers and non-carriers of the ACE I-allele

At baseline, relative, but not absolute, VO2max was lower in carriers than non-carriers of the ACE I-allele (Table 1a). No interaction effect was evident between the ACE I-allele and the co-variable of ‘body weight’ for absolute and relative VO2max (p > 0.69). At the muscle level (Fig. 1), capillary density in vastus lateralis muscle was lower in carriers of the ACE I-allele.

The ACE I-allele modulates the muscle response to bicycle type endurance training

Absolute and relative VO2max was improved by 9 and 10 %, respectively, after bicycle type of endurance training (Table 2a). Bicycle training also increased the volume density of subsarcolemmal and total mitochondria and intramyocellular lipid in vastus lateralis muscle. The volume density of subsarcolemmal mitochondria and intramyocellular lipid demonstrated an interaction effect between the ‘ACE I-allele’ and ‘training’ (Fig. 2). Volume density of subsarcolemmal mitochondria was 3.3-fold and intramyocellular lipid was 3.1-fold elevated after bicycle training in carriers of the ACE I-allele. ACE-DD genotypes demonstrated a lower degree of volumetric increase in subsarcolemmal mitochondria and no change in intramyocellular lipid (Fig. 2).

ACE I-allele modulated local aerobic capacity depends on exercise type

Running type endurance training increased absolute and relative VO2max by 8 and 9 %, respectively (Table 2b). As well, total mitochondrial density in vastus lateralis muscle was increased after running training and this distinguished to the effect of bicycle training (compare Table 2a, b). There was an interaction effect of ‘exercise type’ and ‘ACE I-allele’ for the fold changes of combined muscle parameters with endurance training (p = 0.024). No effect of the ACE I-allele on training-induced adjustments was observed in the running group (p values > 0.23).

Exposing the molecular pathway of the ACE-dependent training response

24 of the 231 assessed muscle transcripts demonstrated level regulation after the first endurance exercise test and endurance training on the bicycle. The levels of 15 gene transcripts demonstrated ACE I-allele-dependent regulation during recovery from bicycle exercise and training (Fig. 3a). The majority of these were associated with glucose (i.e. Glut2, LDHC) and lipid metabolism (CPTII, LIPE, FATP, CD36/FAT) and metabolic regulation (HIF-1a, VHL, GIP, Il-6RST, IGF-II). 8 further gene transcripts associated with metabolic processes (i.e. ALDO C, CPTI, IL-6, ACADL, LPL, PDHA2, PPARA, PGF) demonstrated ACE I-allele dependent expression with training (Fig. 3b); all transcript changes with training showing a reduced magnitude in non-carriers of the ACE I-allele.


Discussion

Supply of metabolic substrates into working muscle is an important component of endurance exercise capacity. Our present investigation shows that variants of the ACE insertion/deletion polymorphism fundamentally differ in muscle capillarity and the response of muscle mitochondria and intramyocellular lipid content to repeated endurance exercise. Transcript profiling exposed a number of genes associated with carbohydrate and lipid metabolism in skeletal muscle as targets of a novel, ACE modulated expression pathway being activated by endurance exercise (Fig. 4).

A number of limitations related to sample size for a genetic study, control of metabolite supply and protein verification of identified transcript differences, may be worth considering in the interpretation of our results. We note that the absence of a rigorous control for nutrient intake may produce uncertainty in our conclusions. Thus, our conclusions may be considered as preliminary as we cannot exclude that lifestyle associated factors have contributed to the observed effect of the ACE insertion allele on changes in intramyocellular lipid volume density after endurance training. Also, due to limitations in available amount of biological tissue, we were not able to assess whether expressional adjustments of proteins encoded by the genotype-affected transcripts (Fig. 4) underline the identified changes. Regarding the higher capillarity in the extensor muscle, M. vastus lateralis, of our Swiss ACE-DD genotypes before training, we find that this is consistent with the concomitantly elevated relative VO2max (Table 1a) as expected from the contribution of oxygen delivery to extensor muscle groups during the dynamic knee extensor exercise of bicycling (Krustrup et al. 2004). This observation is in line with other Caucasian populations [reviewed by (Flueck et al. 2010)] while being at variance with early studies of Montgomery in trained British men [reviewed in (Puthucheary et al. 2011)]. In trying to address the role of exercise in potentially ACE I-allele modulated muscle plasticity, we assessed the effect of bicycle type endurance training on ultrastructure and transcript expression in vastus lateralis muscle. Because the association between endurance phenotypes and the ACE I-allele has been studied in endurance runners and cyclists (Alvarez et al. 2000; Myerson et al. 1999), we opted to compare the results of bicycle versus running type of endurance training. The amplified adjustments of myocellular organelles (Fig. 2) and gene transcripts being associated with mitochondrial lipid metabolism after supervised bicycle training (Fig. 3a) is in agreement with the hypothesis suggested from the literature on elevated trainability of endurance performance in subjects carrying the ACE I-allele (Myerson et al. 1999). Thus, our observations allow to draw a number of mechanistically important conclusions on the contribution of skeletal muscle to ACE modulated exercise performance and its molecular underpinning.

The higher capillary-to-fibre ratio and capillary density in vastus lateralis muscle in untrained participants with the ACE-DD genotype (Table 1b) exposed that the ACE I/D genotype modifies muscle quality by an effect on angiogenesis. It has been demonstrated that the product(s) of the ACE gene product, angiotensin 2 and bradykinin, are potent stimulators of angiogenesis in model systems (Amaral et al. 2001; Heffelfinger 2007; Petersen and Greene 2007). In this regard, it is of note that non-carriers of the ACE-I allele demonstrate elevated ACE activity (Alvarez et al. 2000; Danser et al. 2007; Rigat et al. 1990). Our present novel observation indicates that genetic regulation of ACE affects in addition to the acute regulation of vascular tone (Santana et al. 2011) also the structural aspects of muscle perfusion.

In contrast to our hypothesis, muscle capillarity was not differently affected between carriers and non-carriers of the ACE I-allele with bicycle type or running type endurance exercise (Fig. 2, data not shown). The detailed inspection of the transcript response after bicycling identified, however, two factors being associated with angiogenesis (i.e. PGF and MMP-10) whose expression in exercised muscle was affected by the ACE I-allele (Fig. 3a). Adjustments in muscle capillarity with endurance training are known to grade to exercise intensity and manifest predominantly after high intensity protocols of training (Egginton et al. 2001; Jensen et al. 2004; Lampert et al. 1998). Combined, these findings suggest that the investigated endurance protocols did not create the biological context, to resolve whether an exercise-mediated mechanism contributes to ACE modulated capillarity.

Conversely, we observe a specifically enhanced improvement in volume density of subsarcolemmal mitochondria and intramyocellular lipid in vastus lateralis muscle with bicycle training in carriers of the ACE I-allele (Fig. 2). This finding points towards a role for the ACE I/D polymorphism in regulating local adjustments in aerobic metabolism in a major extensor muscle. The concomitantly amplified up-regulation of transcripts for factors of lipid and carbohydrate metabolism in carriers of the ACE I-allele during recovery from endurance exercise and training (Fig. 4) identifies that a novel ACE I-allele modulated expression pathway contributes to the conditioning of muscle’s aerobic capacity in men. In this context it is of interest that carriers of the ACE I-allele demonstrated reduced muscle capillarity and maximal oxygen uptake at baseline (Table 1b). The observations in our population support the hypothesis that remodelling of aerobic substrate pathways in skeletal muscle contributes to the reported superior trainability of endurance performance in carriers of the ACE I-allele (Cam et al. 2007; Flueck et al. 2010).

A specific observation of our study was that the ultrastructural adjustments in the knee extensor muscle, vastus lateralis, differed between bicycle and running type endurance exercise despite a similar increase in maximal oxygen uptake (Table 2). This is in line with the pronounced effects of the employed bicycle paradigm on mitochondrial volume density in vastus lateralis muscle (Hoppeler et al. 1985; Hoppeler and Weibel 1998). It possibly reflects a more important contribution of the investigated extensor muscle to power output during a bicycle than running type workout. Possibly, the self-controlled nature of the running training, despite being verified for compliance, contributed to the observed differences in adaptations between the two types of endurance training, as well. The superior myocellular adjustments in the volume density of subsarcolemmal mitochondrial and intramyocellular lipid stores after bicycle type compared to running type endurance training, and their dependence on the ACE I-allele is in agreement with the idea that the association between the ACE I-allele polymorphism and endurance performance is intensity dependent (Cam et al. 2007). Our findings now point out that the exercise type is a potential confounding variable when interpreting results from genetical studies into human performance.

In contrast to elevated subsarcolemmal mitochondria density in carriers of the ACE I-allele after bicycle training, the improvements in absolute and relative VO2max were not significantly affected by the ACE I/D polymorphism (Fig. 2). This suggests that the ACE genotype may influence aspects of mitochondrial metabolism that do not necessary manifest in elevated aerobic capacity. In this regard, it is of interest that subsarcolemmal mitochondria relate to a better use of blood-borne substrate following endurance exercise [reviewed in (Lampert et al. 1998)] as they situate in vicinity to capillaries (Fig. 1). This view is supported by the specific higher up-regulation of transcripts involved in mitochondrial beta oxidation (CPTI, CPTII, ACADL), but not the electron transport chain after training in carriers compared to non-carriers of the ACE I-allele (Fig. 4).

In support of modified metabolism in exercised muscle between genotypes, we identify a selective increase in intramyocellular lipid density after endurance training in carriers of the ACE I-allele. Our observation represents to the best of our knowledge the first documentation of ACE-related muscle lipid content in healthy humans after training. Interestingly, exercise-induced hypotension, reflecting elevated muscle perfusion, is confined to carriers of the ACE I-allele (Santana et al. 2011). Muscle perfusion likely affects intramyocellular lipid stores as these arise through the esterification of fatty acids taken up from the vasculature into perfused muscle during recovery from exercise and synthesis from long-chain fatty acids (Jayakumar et al. 1995; Kiens 2006). In this regard, it is of note that transcript profiling identified pronounced ACE I-allele dependent up-regulation of two transcripts involved in fatty acid mobilisation (i.e. CD36/FAT, FATP) during the first 24 h of recovery from exercise and after training (Fig. 3a). As well, the LPL transcript for lipoprotein lipase was selectively increased in carriers of the ACE I-allele after bicycle training (Fig. 3b). FATP (fatty acid transport protein) and CD36/FAT (fatty acid translocase) and LPL encode factors being involved in the uptake of free fatty acids in muscle fibers during recovery from exercise (Bonen et al. 2004; Kiens 2006). The findings indicate a role of the ACE I/D polymorphism in an expressional mechanism setting the improvement in uptake capacity for free fatty acids into skeletal muscle and intramyocellular lipid accumulation after repeated endurance exercise stimulus. The content of intramyocellular lipid relies, however, on multiple biochemical reactions. In this regard, it is of note that the LIPE transcript levels for the suspected major lipase for hydrolysis of stored triacylglycerol in skeletal muscle showed ACE-genotype modulated regulation after endurance training (Fig. 3a). This emphasises that multifactorial expressional mechanism possibly mediates the indicated effects of the ACE I-allele on lipid metabolism in skeletal muscle.

Support for a broader influence of the ACE I/D polymorphism on metabolic regulation is provided by elevated muscle transcript levels of transcriptional regulators of lipid (i.e. PPARA) and carbohydrate/mitochondrial metabolism (i.e. HIF-1a, VHL) and three glycolytic factors after single or repeated exercise in carriers of the ACE I-allele (Fig. 4). HIF-1a is the hypoxia-regulated subunit of the hypoxia-inducible transcription factor HIF-1 that is stabilized by VHL. Increased levels of the HIF-1a transcript promote mitochondrial and glycolysis related transcript expression in mouse skeletal muscle (Däpp et al. 2006), the human homologues of five of which (i.e. ACADL, Glut2, LDHC, LPL) demonstrated ACE I-allele related expression after bicycle endurance training (Fig. 4). Given that the ACE-DD genotypes of our study group show elevated capillarity before, and after, endurance training (Table 1b, data not shown) this bears the question whether the promoted expression of metabolic features after bicycle training in carriers of the ACE I-allele reflects a strategy to compensate enhanced local metabolic strain during endurance exercise (reviewed in Schmutz et al. 2010).


Conclusions

Our findings indicate that ACE I-allele modulated capillary supply lines affect adjustments in mitochondrial lipid metabolism in skeletal muscle in relation to altered transcript expression after intense endurance exercise. ACE I-allele modulated metabolic gene expression is suggested as a partial explanation for the superior response of endurance capacity to endurance training in human subjects with the ACE I-allele.


This study was supported by a start up grant from Manchester Metropolitan University (MF) and the Swiss National Science Foundation (MF).


References
Almeida SS,Barros CC,Moraes MR,Russo FJ,Haro AS,Rosa TS,Alves MF,Pesquero JB,Carmona AK,Bacurau RF,Araujo RC. Plasma Kallikrein and Angiotensin I-converting enzyme N- and C-terminal domain activities are modulated by the insertion/deletion polymorphismNeuropeptidesYear: 20104413914310.1016/j.npep.2009.12.00320064660
Alvarez R,Terrados N,Ortolano R,Iglesias-Cubero G,JR R,Batalla A,Cortina A,Fernández-García B,Rodríguez C,Braga S,Alvarez V,Coto E. Genetic variation in the renin-angiotensin system and athletic performanceEur J Appl PhysiolYear: 20008211712010.1007/s00421005066010879452
Amaral SL,Linderman JR,Morse MM,Greene AS. Angiogenesis induced by electrical stimulation is mediated by angiotensin II and VEGFMicrocirculationYear: 20018576711296854
Baker J,Davids K. Gene and environmental constraints on variability in sports performance. Movement system variabilityYear: 2006Urbana ChampaignHuman Kinetics109129
Bellamy LM,Johnston AP,De Lisio M,Parise G. Skeletal muscle-endothelial cell cross talk through angiotensin IIAm J Physiol Cell PhysiolYear: 2010299C1402C140810.1152/ajpcell.00306.201020861465
Bonen A,Campbell SE,Benton CR,Chabowski A,Coort SL,Han XX,Koonen DP,Glatz JF,Luiken JJ. Regulation of fatty acid transport by fatty acid translocase/CD36Proc Nutr SocYear: 20046324524910.1079/PNS200433115294038
Bouchard C,Rankinen T. Individual differences in response to regular physical activityMed Sci Sports and ExercYear: 200133S446S45110.1097/00005768-200106001-0001311427769
Bray MS,Hagberg JM,Pérusse L,Rankinen T,Roth SM,Wolfarth B,Bouchard C. The human gene map for performance and health-related fitness phenotypes: the 2006–2007 updateMed Sci Sports and ExercYear: 200941357310.1249/MSS.0b013e318184417919123262
Brothers RM,Haslund ML,Wray DW,Raven PB,Sander M. Exercise-induced inhibition of angiotensin II vasoconstriction in human thigh muscleJ PhysiolYear: 200657772773710.1113/jphysiol.2006.11397716973706
Cam S,Colakoglu M,Colakoglu S,Sekuri C,Berdeli A. ACE I/D gene polymorphism and aerobic endurance development in response to training in a non-elite female cohortJ Sports Med Phys FitnessYear: 20074723423817557065
Danser AH,Batenburg WW,van den Meiracker AH,Danilov SM. ACE phenotyping as a first step toward personalized medicine for ACE inhibitors. Why does ACE genotyping not predict the therapeutic efficacy of ACE inhibition?Pharmacol TherYear: 200711360761810.1016/j.pharmthera.2006.12.00117257685
Dietze GJ,Henriksen EJ. Angiotensin-converting enzyme in skeletal muscle: sentinel of blood pressure control and glucose homeostasisJ Renin Angiotensin Aldosterone SystYear: 20089758810.3317/jraas.2008.01118584583
Egginton S,Zhou AL,Brown MD,Hudlicka O. Unorthodox angiogenesis in skeletal muscleCardiovasc ResYear: 20014963464610.1016/S0008-6363(00)00282-011166277
Evans AE, Poirier O, Kee F, Lecerf L, McCrum E, Falconer T, Crane J, O'Rourke DF, Cambien F (1994) Polymorphisms of the angiotensin-converting-enzyme gene in subjects who die from coronary heart disease. Q J Med 87:211–214
Flueck M,Vaughan D,Westerblad H. Linking genes with exercise: where is the cut-off?Eur J Appl PhysiolYear: 20101101095109810.1007/s00421-010-1662-920941629
Heffelfinger SC. The renin angiotensin system in the regulation of angiogenesisCurr Pharm DesYear: 2007131215122910.2174/13816120778061885817504231
Hoppeler H,Weibel ER. Limits for oxygen and substrate transport in mammalsJ Exp BiolYear: 1998201105110649510519
Hoppeler H,Howald H,Conley K,Lindstedt SL,Claassen H,Vock P,Weibel ER. Endurance training in humans: aerobic capacity and structure of skeletal muscleJ Appl PhysiolYear: 1985593203274030584
Jamerson K,Nesbitt S,Amerena J,Grant E. Angiotensin mediates forearm glucose uptake by hemodynamic rather than direct effectsHypertensionYear: 199627485485810.1161/01.HYP.27.4.8548613260
Jayakumar A,Tai MH,Huang WY,al-Feel W,Hsu M,Abu-Elheiga L,Chirala SS,Wakil SJ. Human fatty acid synthase: properties and molecular cloningProc Natl Acad Sci USAYear: 1995928695869910.1073/pnas.92.19.86957567999
Jensen L,Bangsbo J,Hellsten Y. Effect of high intensity training on capillarization and presence of angiogenic factors in human skeletal muscleJ PhysiolYear: 200455757158210.1113/jphysiol.2003.05771115020701
Jones A,Montgomery HE,Woods DR. Human performance: a role for the ACE genotype?Exerc Sport Sci RevYear: 20023018419010.1097/00003677-200210000-0000812398116
Kiens B. Skeletal muscle lipid metabolism in exercise and insulin resistancePhysiol RevYear: 20068620524310.1152/physrev.00023.200416371598
Krustrup P,Soderlund K,Mohr M,Gonzalez-Alonso J,Bangsbo J. Recruitment of fibre types and quadriceps muscle portions during repeated, intense knee-extensor exercise in humansPflugers ArchYear: 2004449566510.1007/s00424-004-1304-315290298
Lampert E,Mettauer B,Hoppeler H,Charloux A,Charpentier A,Lonsdorfer J. Skeletal muscle response to short endurance training in heart transplant recipientsJ Am Coll CardiolYear: 19983242042610.1016/S0735-1097(98)00227-79708470
Lester S,Heatley S,Bardy P,Bahnisch J,Bannister K,Faull R,Clarkson A. The DD genotype of the angiotensin-converting enzyme occurs in very low frequency in Australian AboriginalsNephrol Dial TransplantYear: 1999488789010.1093/ndt/14.4.88710328464
Munzenmaier DH,Greene AS. Opposing actions of angiotensin II on microvascular growth and arterial blood pressureHypertensionYear: 19962776076510.1161/01.HYP.27.3.7608613237
Myerson S,Hemingway H,Budget R,Martin J,Humphries S,Montgomery H. Human angiotensin I-converting enzyme gene and endurance performanceJ Appl PhysiolYear: 1999871313131610517757
Petersen MC,Greene AS. Angiotensin II is a critical mediator of prazosin-induced angiogenesis in skeletal muscleMicrocirculationYear: 20071458359110.1080/1073968070140469717710629
Puthucheary Z,Skipworth JR,Rawal J,Loosemore M,Van Someren K,Montgomery HE. The ACE gene and human performance: 12 years onSports MedYear: 20114143344810.2165/11588720-000000000-0000021615186
Rigat B,Hubert C,Alhenc-Gelas F,Cambien F,Corvol P,Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levelsJ Clin InvestYear: 1990861343134610.1172/JCI1148441976655
Santana HA,Moreira SR,Neto WB,Silva CB,Sales MM,Oliveira VN,Asano RY,Espindola FS,Nobrega OT,Campbell CS,Simoes HG. The higher exercise intensity and the presence of allele I of ACE gene elicit a higher post-exercise blood pressure reduction and nitric oxide release in elderly women: an experimental studyBMC Cardiovasc DisordYear: 2011117110.1186/1471-2261-11-7122136292
Schmutz S,Dapp C,Wittwer M,Vogt M,Hoppeler H,Fluck M. Endurance training modulates the muscular transcriptome response to acute exercisePflugers ArchYear: 200645167868710.1007/s00424-005-1497-016362354
Schmutz S,Dapp C,Wittwer M,Durieux AC,Mueller M,Weinstein F,Vogt M,Hoppeler H,Flueck M. A hypoxia complement differentiates the muscle response to endurance exerciseExp PhysiolYear: 201095672373510.1113/expphysiol.2009.05102920176680
Song R,Preston G,Yosypiv IV. Angiotensin II stimulates in vitro branching morphogenesis of the isolated ureteric budMech DevYear: 20111287–1035936710.1016/j.mod.2011.07.00221820050
Suter E,Hoppeler H,Claassen H,Billeter R,Aebi U,Horber F,Jaeger P,Marti B. Ultrastructural modification of human skeletal muscle tissue with 6-month moderate-intensity exercise trainingInt J Sports MedYear: 19951616016610.1055/s-2007-9729857649706
Timmons JA. Variability in training-induced skeletal muscle adaptationJ Appl PhysiolYear: 201111084685310.1152/japplphysiol.00934.201021030666
Tusher VG,Tibshirani R,Chu G. Significance analysis of microarrays applied to the ionizing radiation responseProc Natl Acad Sci USAYear: 2001985116512110.1073/pnas.09106249811309499
Woods DR,World M,Rayson MP,Williams AG,Jubb M,Jamshidi Y,Hayward M,Mary DA,Humphries SE,H.E M,H.E M. Endurance enhancement related to the human angiotensin I-converting enzyme I-D polymorphism is not due to differences in the cardiorespiratory response to trainingEur J Appl PhysiolYear: 20028624024410.1007/s00421-001-0545-511990733
Yan Z,Okutsu M,Akhtar YN,Lira VA. Regulation of exercise-induced fiber type transformation, mitochondrial biogenesis, and angiogenesis in skeletal muscleJ Appl PhysiolYear: 201111026427410.1152/japplphysiol.00993.201021030673
Zhang B,Tanaka H,Shono N,Miura S,Kiyonaga A,Shindo M,Saku K. The I allele of the angiotensin-converting enzyme gene is associated with an increased percentage of slow-twitch type I fibers in human skeletal muscleClin GenetYear: 20036313914410.1034/j.1399-0004.2003.00029.x12630962
Zhang B,Shono N,Fan P,Ando S,Xu H,Jimi S,Miura S,Kumagai K,Win KM,Matsunaga A,Iwasaski H,Saku K. Histochemical characteristics of soleus muscle in angiotensin-converting enzyme gene knockout miceHypertens ResYear: 20052868168810.1291/hypres.28.68116392773

Figures

[Figure ID: Fig1]
Fig. 1 

ACE I-allele dependent effects on muscle-related parameters of fitness. Representative micrograph indicating the assessed ultra-structural parameters in vastus lateralis muscle



[Figure ID: Fig2]
Fig. 2 

ACE I-allele dependent muscle adjustments to endurance training. Bar graph of mean + SE of fold changes in muscle parameters and VO2max in carriers and non-carriers of the ACE I-allele after bicycle training. n = 9 with no I-allele, 7 with I-allele. Vv volume density. *, p < Bonferroni-corrected 0.05 for post versus pre changes (paired T-test). # denotes a significant interaction effect between the fold-changes (‘post vs. pre-training’) and the ‘ACE I-allele’ at p < Bonferroni-corrected 0.05 (repeated ANOVA)



[Figure ID: Fig3]
Fig. 3 

Genotype dependent expression changes to endurance exercise. a Heat map visualizing the regulation of the 15 gene transcripts and their functional ontology demonstrating level differences between carriers and non-carriers of the ACE I-allele in vastus lateralis muscle during recovery from bicycle exercise and after bicycle training. Colour code denotes the scale of fold changes 1, 8, 24 h after endurance exercise and training versus baseline in carriers of the I-allele, non-carriers of the I-allele, and the corresponding ratio between the two genotypes. b Bar graph of mean + SE for fold changes in training-induced expression for 8 transcripts which distinguished between ACE genotypes after training. #, q-value <5 %/231 for differences in fold changes between genotypes. n = 12. For abbreviations see legend to Fig. 4



[Figure ID: Fig4]
Fig. 4 

Summary of ACE I-allele affected pathways Genmapp visualizing the metabolic pathways holding gene transcripts with ACE I/D genotype dependent expression post exercise/training. The assessed transcripts are given in boxes with the colour coding indicting a significant genotype effect. ACADL long chain acyl-CoA dehydrogenase, ACTN1 actinin alpha 1, ALDOC aldolase C, COL4A1 collagen type IV alpha 1, CPTI carnitine palmitoyltransferase I, CPTII Carnitine palmitoyltransferase II, CD36/FAT cluster of Differentiation 36)/fatty acid translocase, ETC. electron transport chain, FATP fatty acid transport protein, GIP glucose-dependent insulinotropic peptide, Glut2 Glucose transporter 2, HIF-1a subunit alpha of hypoxia-inducible factor 1, HO-1 heme oxygenase 1, IGF-II insulin-like growth factor II, IL-6 interleukin 6, Il-6RST interleukin 6 receptor signal transducer, LDHC lactate dehydrogenase C, LIPE hormone sensitive lipase transcript, LPL lipoprotein lipase, MMP-10 metalloproteinase 10, PDHA2 pyruvate dehydrogenase alpha 2, PGF placental growth factor, PPARA Peroxisome proliferator-activated receptor alpha, VHL von Hippel Landau tumour suppressor. For further abbreviations consult www.expasy.org



Tables
[TableWrap ID: Tab1] Table 1 

Differences in whole body (a) and muscle parameters (b) between carriers of the ACE I-allele (i.e. combined ACE-ID and ACE-II genotypes) and non-carriers (i.e. ACE-DD genotype) in the studied Swiss men before endurance training


Genotype Non-carriers Carriers p value
a)
Age (years) 29.9 ± 2.2 33.7 ± 1.9 0.21
Height (m) 178.2 ± 1.9 177.2 ± 1.7 0.72
Body weight (kg) 73.2 ± 2.2 80.2 ± 3.5 0.14
BMI (kg m-2) 23.0 ± 0.4 25.5 ± 1.0 0.05
VO2max [L O2 min-1] 3.43 ± 0.17 3.06 ± 0.13 0.10
VO2max [mL O2 min-1 kg-1] 47.1 ± 2.3 39.4 ± 1.8 0.01
n 14 21
b)
Fibre CSA (μm2) 3408 ± 242 3586 ± 226 0.60
Slow fibre type (%) 50.8 ± 4.9 51.3 ± 2.4 0.20
Capillary-to-fibre ratio 1.8 ± 0.1 1.5 ± 0.1 0.05
Capillary density (mm-2) 540.4 ± 26.5 438.9 ± 16.8 0.002
Total mitochondria Vv (%) 5.1 ± 0.3 4.8 ± 0.3 0.48
Subs. mitochondria Vv (%) 0.8 ± 0.1 0.8 ± 0.1 0.71
Intramyocellular lipid Vv (%) 0.6 ± 0.1 0.6 ± 0.1 0.94
Residual Vv (%) 13.7 ± 0.8 12.3 ± 0.4 0.08
n 14 21

Data refer to mean ± Standard error (SE). P values of two-tailed T-test passing a Bonferroni-corrected p value < 0.05 are underlined

Vv volume density, subs. subsarcolemmal


[TableWrap ID: Tab2] Table 2 

Adjustments induced in subjects which completed endurance training composed of 6-weeks of supervised bicycle exercise (n = 16, a) or 6-months of self-regulated running (n = 19, b)


Factor Fold p-value
a) bicycling
 Absolute VO2max 1.09 ± 0.02 2E−5
 Relative VO2max 1.10 ± 0.01 2E−6
 Body weight 0.99 ± 0.01 0.26
 Fibre CSA 0.98 ± 0.05 0.76
 Capillary-to-fibre ratio 1.10 ± 0.04 0.02
 Capillary density 1.15 ± 0.06 0.01
 Residual Vv 1.29 ± 0.05 9E−5***
 Myofibre Vv 0.92 ± 0.01 8E−6***
 Intramyocellular lipid Vv 2.13 ± 0.40 7E−4*
 Total mitochondria Vv 1.43 ± 0.07 2E−6*
 Subsarcolemmal mitochondria Vv 2.50 ± 0.36 1E−5**
 Central mitochondria Vv 1.28 ± 0.06 8E−5
b) running
 Absolute VO2max 1.08 ± 0.02 3E−3
 Relative VO2max 1.09 ± 0.03 3E−3
 Body weight 1.00 + 0.04 0.20
 Fibre CSA 1.03 ± 0.04 0.58
 Capillary-to-fibre ratio 1.06 ± 0.04 0.15
 Capillary density 1.05 ± 0.04 0.36
 Residual Vv 0.99 ± 0.04 0.76
 Myofibre Vv 0.99 ± 0.01 0.31
 Intramyocellular lipid Vv 1.11 ± 0.18 0.49
Total mitochondria Vv 1.21 ± 0.06 4E−3
 Subsarcolemmal mitochondria Vv 1.60 ± 0.23 0.07
 Central mitochondria Vv 1.17 ± 0.06 0.01

P-values of paired T tests passing a Bonferroni correction are underlined

Vv volume density

*, ** and ***, respectively, denote p-values <0.05, <0.01 and <0.001 for the comparison of fold changes after bicycle versus running type endurance training



Article Categories:
  • Original Article

Keywords: Keywords Vasoconstriction, Metabolism, Exercise, Human, Genetical genomics, Aerobic capacity, Capillary.

Previous Document:  Explicit Beliefs about Aggression, Implicit Knowledge Structures, and Teen Dating Violence.
Next Document:  Cause-Specific Mortality in Patients with Mucoepidermoid Carcinoma of the Major Salivary Glands.